Category: Technology (2)

Category: Technology (2)

Technology Partners

Kytopen and Mirus Bio Announce Partnership to Unlock New and Scalable Genome Engineering Capabilities for the Next-Generation of Living Medicines

The two companies will collaborate to combine industry-leading technologies and tackle the...
Kytopen
February 07, 2023
Technology

Kytopen awarded NIH grant of up to $2M to unlock the power of engineered Natural Killer (NK) cells via Flowfect® platform

NIH/NIAID SBIR Fast Track grant accelerates the company’s commercial activities towards a non-viral...
Kytopen
June 15, 2021
Technology

Rapid discovery and manufacture of next-generation cell therapies

MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect™...
Kytopen
January 20, 2021
Technology

Flowfect™ Tx Revealed

Kytopen, an MIT spin-out company, and Cambridge Consultants, part of Capgemini, announce the...
Kytopen
October 28, 2020